ID   SIA7C_MOUSE             Reviewed;         305 AA.
AC   Q9WUV2; Q9JHP5;
DT   11-JUL-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 2.
DT   07-APR-2021, entry version 135.
DE   RecName: Full=Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3;
DE            EC=2.4.99.7 {ECO:0000269|PubMed:10207017};
DE   AltName: Full=GalNAc alpha-2,6-sialyltransferase III;
DE   AltName: Full=ST6GalNAc III {ECO:0000303|PubMed:10207017, ECO:0000303|PubMed:10601645};
DE            Short=ST6GalNAcIII;
DE   AltName: Full=STY;
DE   AltName: Full=Sialyltransferase 7C;
DE            Short=SIAT7-C;
GN   Name=St6galnac3; Synonyms=Siat7c;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=ICR; TISSUE=Brain;
RX   PubMed=10207017; DOI=10.1074/jbc.274.17.11958;
RA   Lee Y.-C., Kaufman M., Kitazume-Kawaguchi S., Kono M., Takashima S.,
RA   Kurosawa N., Liu H., Pircher H., Tsuji S.;
RT   "Molecular cloning and functional expression of two members of mouse NeuAc-
RT   alpha-2,3Gal-beta-1,3GalNAc GalNAc-alpha2,6-sialyltransferase family,
RT   ST6GalNAc III and IV.";
RL   J. Biol. Chem. 274:11958-11967(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=10601645; DOI=10.1016/s0014-5793(99)01605-1;
RA   Ikehara Y., Shimizu N., Kono M., Nishihara S., Nakanishi H., Kitamura T.,
RA   Narimatsu H., Tsuji S., Tatematsu M.;
RT   "A novel glycosyltransferase with a polyglutamine repeat; a new candidate
RT   for GD1alpha synthase (ST6GalNAc V).";
RL   FEBS Lett. 463:92-96(1999).
CC   -!- FUNCTION: Transfers the sialyl group (N-acetyl-alpha-neuraminyl or
CC       NeuAc) from CMP-NeuAc to the GalNAc residue on the NeuAc-alpha-2,3-Gal-
CC       beta-1,3-GalNAc sequence of glycoproteins and glycolipids forming an
CC       alpha-2,6-linkage. Produces branched type disialyl structures by
CC       transfer of a sialyl group onto a GalNAc residue inside the backbone
CC       core chains. ST6GalNAcIII prefers glycolipids to glycoproteins,
CC       predominantly catalyzing the biosynthesis of ganglioside GD1alpha from
CC       GM1b (PubMed:10207017, PubMed:10601645). GD1alpha is a critical
CC       molecule in the communication and interaction between neuronal cells
CC       and their supportive cells, particularly in brain tissues, and
CC       functions as an adhesion molecule in the process of metastasis (By
CC       similarity). Sialylation of glycoproteins or glycosphingolipids is very
CC       important in tumor development, neuronal development, nerve repair,
CC       immunological processes and regulation of hormone sensitivity (By
CC       similarity). {ECO:0000250|UniProtKB:Q8NDV1,
CC       ECO:0000250|UniProtKB:Q9QYJ1, ECO:0000269|PubMed:10207017,
CC       ECO:0000269|PubMed:10601645}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-D-GlcNAc derivative +
CC         CMP-N-acetyl-beta-neuraminate = an alpha-Neu5Ac-(2->3)-beta-D-Gal-
CC         (1->3)-[alpha-Neu5Ac-(2->6)]-D-GlcNAc-R + CMP + H(+);
CC         Xref=Rhea:RHEA:53896, ChEBI:CHEBI:15378, ChEBI:CHEBI:57812,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:146021, ChEBI:CHEBI:149714;
CC         EC=2.4.99.7; Evidence={ECO:0000269|PubMed:10207017};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53897;
CC         Evidence={ECO:0000305|PubMed:10207017};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=CMP-N-acetyl-beta-neuraminate + ganglioside GM1b (d18:1(4E)) =
CC         a ganglioside GD1alpha (d18:1(4E)) + CMP + H(+);
CC         Xref=Rhea:RHEA:41968, ChEBI:CHEBI:15378, ChEBI:CHEBI:57812,
CC         ChEBI:CHEBI:60377, ChEBI:CHEBI:78568, ChEBI:CHEBI:78569;
CC         Evidence={ECO:0000269|PubMed:10207017, ECO:0000305|PubMed:10601645};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41969;
CC         Evidence={ECO:0000305|PubMed:10207017, ECO:0000305|PubMed:10601645};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=CMP-N-acetyl-beta-neuraminate + globoside MSGG = CMP +
CC         globoside DSGG + H(+); Xref=Rhea:RHEA:56088, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57812, ChEBI:CHEBI:60377, ChEBI:CHEBI:140623,
CC         ChEBI:CHEBI:140624; Evidence={ECO:0000250|UniProtKB:Q8NDV1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:56089;
CC         Evidence={ECO:0000250|UniProtKB:Q8NDV1};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=alpha-NeuNAc-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1<->1')-
CC         L-Ser-[protein] + CMP-N-acetyl-beta-neuraminate = alpha-NeuNAc-
CC         (2->3)-beta-D-Gal-(1->3)-[alpha-NeuNAc-(2->6)]-alpha-D-GalNAc-
CC         (1<->1')-L-Ser-[protein] + CMP + H(+); Xref=Rhea:RHEA:65280,
CC         Rhea:RHEA-COMP:16760, Rhea:RHEA-COMP:16761, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57812, ChEBI:CHEBI:60377, ChEBI:CHEBI:156395,
CC         ChEBI:CHEBI:156397; Evidence={ECO:0000269|PubMed:10207017};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65281;
CC         Evidence={ECO:0000305|PubMed:10207017};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=alpha-NeuNAc-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1<->1')-
CC         L-Thr-[protein] + CMP-N-acetyl-beta-neuraminate = alpha-NeuNAc-
CC         (2->3)-beta-D-Gal-(1->3)-[alpha-NeuNAc-(2->6)]-alpha-D-GalNAc-
CC         (1<->1')-L-Thr-[protein] + CMP + H(+); Xref=Rhea:RHEA:65284,
CC         Rhea:RHEA-COMP:16762, Rhea:RHEA-COMP:16763, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57812, ChEBI:CHEBI:60377, ChEBI:CHEBI:156396,
CC         ChEBI:CHEBI:156398; Evidence={ECO:0000269|PubMed:10207017};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65285;
CC         Evidence={ECO:0000305|PubMed:10207017};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000305|PubMed:10207017, ECO:0000305|PubMed:10601645}.
CC   -!- PATHWAY: Glycolipid biosynthesis. {ECO:0000305|PubMed:10207017,
CC       ECO:0000305|PubMed:10601645}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus membrane {ECO:0000305}; Single-
CC       pass type II membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: In adult tissues, high expression in brain, lung
CC       and heart and to a lesser extent in kidney, mammary gland, spleen,
CC       testis and thymus. {ECO:0000269|PubMed:10207017}.
CC   -!- DEVELOPMENTAL STAGE: In brain, expression reaches maximum levels at day
CC       12 of the embryonic stage. Keeps almost similar levels during mouse
CC       development. {ECO:0000269|PubMed:10207017}.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 29 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase; Note=ST6GalNAc
CC       III;
CC       URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_mou_652";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y11342; CAA72181.2; -; mRNA.
DR   EMBL; Y11343; CAB95031.1; -; Genomic_DNA.
DR   EMBL; Y11344; CAB95031.1; JOINED; Genomic_DNA.
DR   EMBL; Y11345; CAB95031.1; JOINED; Genomic_DNA.
DR   EMBL; Y11346; CAB95031.1; JOINED; Genomic_DNA.
DR   EMBL; BC058387; AAH58387.1; -; mRNA.
DR   CCDS; CCDS38677.1; -.
DR   RefSeq; NP_035502.1; NM_011372.2.
DR   STRING; 10090.ENSMUSP00000068598; -.
DR   SwissLipids; SLP:000000783; -.
DR   CAZy; GT29; Glycosyltransferase Family 29.
DR   GlyGen; Q9WUV2; 2 sites.
DR   MaxQB; Q9WUV2; -.
DR   PaxDb; Q9WUV2; -.
DR   PRIDE; Q9WUV2; -.
DR   ProteomicsDB; 257234; -.
DR   Antibodypedia; 33477; 49 antibodies.
DR   Ensembl; ENSMUST00000200397; ENSMUSP00000143747; ENSMUSG00000052544.
DR   GeneID; 20447; -.
DR   KEGG; mmu:20447; -.
DR   UCSC; uc008rtw.1; mouse.
DR   CTD; 256435; -.
DR   MGI; MGI:1341828; St6galnac3.
DR   eggNOG; KOG2692; Eukaryota.
DR   GeneTree; ENSGT00940000159735; -.
DR   HOGENOM; CLU_061099_2_2_1; -.
DR   InParanoid; Q9WUV2; -.
DR   OMA; YCKSEGF; -.
DR   OrthoDB; 817470at2759; -.
DR   PhylomeDB; Q9WUV2; -.
DR   TreeFam; TF352818; -.
DR   Reactome; R-MMU-4085001; Sialic acid metabolism.
DR   Reactome; R-MMU-977068; Termination of O-glycan biosynthesis.
DR   UniPathway; UPA00378; -.
DR   BioGRID-ORCS; 20447; 1 hit in 52 CRISPR screens.
DR   ChiTaRS; St6galnac3; mouse.
DR   PRO; PR:Q9WUV2; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   RNAct; Q9WUV2; protein.
DR   Bgee; ENSMUSG00000052544; Expressed in metanephric S-shaped body and 225 other tissues.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0047290; F:(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0001665; F:alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity; IBA:GO_Central.
DR   GO; GO:0008373; F:sialyltransferase activity; ISO:MGI.
DR   GO; GO:0001574; P:ganglioside biosynthetic process; IBA:GO_Central.
DR   GO; GO:0009100; P:glycoprotein metabolic process; ISO:MGI.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; ISO:MGI.
DR   GO; GO:0006677; P:glycosylceramide metabolic process; ISO:MGI.
DR   GO; GO:0009311; P:oligosaccharide metabolic process; IBA:GO_Central.
DR   GO; GO:0006486; P:protein glycosylation; ISO:MGI.
DR   Gene3D; 3.90.1480.20; -; 1.
DR   InterPro; IPR001675; Glyco_trans_29.
DR   InterPro; IPR038578; GT29-like_sf.
DR   Pfam; PF00777; Glyco_transf_29; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond; Glycoprotein; Glycosyltransferase; Golgi apparatus;
KW   Membrane; Reference proteome; Sialic acid; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..305
FT                   /note="Alpha-N-acetylgalactosaminide alpha-2,6-
FT                   sialyltransferase 3"
FT                   /id="PRO_0000149276"
FT   TOPO_DOM        1..8
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        9..28
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        29..305
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        239
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        301
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        80..229
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   305 AA;  35414 MW;  63C7498615BF6A3F CRC64;
     MACILKRKPV LVVSFIALCI LLLAMRLVND ATFPLLLNCF GQPKTKWIPL PYTFRQPLRT
     HYGYINVRTQ EPLQLNCNHC AIVSNSGQMV GQKVGEEIDH ASCIWRMNNA PTKGFEEDVG
     YMTMVRVVSH TSVPLLLKNP DYFFKEASRT IYVIWGPFRN MRKDGNGIVY NMLKKTVDAY
     PDAQIYVTTE QQMTHCDRVF KDETGKDRVQ SGSYLSTGWF TFILAMDACY SIHVYGMINE
     TYCKTEGYRK VPYHYYEQGK DECNEYLLHE HAPYGGHRFI TEKKVFAKWA KKHRIVFTHP
     NWTLS
//
